Molina Healthcare will exit the Medicare Advantage Part D business in 2027, the company announced alongside its fourth quarter and full year 2025 earnings report published Feb. 5.
The MAPD product represents approximately $1 billion in annual premiums. Molina said the product does not align with its strategic shift to focus exclusively on its $5 billion dual eligible business, and that underperformance in MAPD is costing it an estimated $1.00 per diluted share in 2026.
For the full year 2025, Molina reported total revenues of $45.4 billion, up 12% year over year. Premium revenue was $43.1 billion, up 11%. Net income was $472 million, down 60% from $1.2 billion in 2024. Adjusted earnings per diluted share were $11.03, down 51% year over year.
The company’s medical loss ratio was 91.7% for the full year, up from 89.1% in 2024, reflecting higher utilization across all segments. The Medicare MLR was 92.4%, driven by higher utilization among high-acuity members, and the marketplace MLR was 90.6%, up sharply from 75.4% in 2024.
As of Dec. 31, Molina had 5.5 million total members, including 4.6 million in Medicaid, 262,000 in Medicare, and 655,000 in marketplace plans.
For 2026, Molina expects premium revenue of approximately $42 billion, a decline of roughly 2%, and adjusted earnings of at least $5.00 per diluted share. The company said its 2026 guidance is burdened by a combined $2.50 per share from a new Florida Medicaid contract implementation and MAPD losses.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
